ArticleCancer discovery2023

Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy.

Takamitsu Hattori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.